Inventiva Announces End of Patient Recruitment for its Phase IIa Trial in the Treatment of MPS VI

Ads

You May Also Like

Arbor Biotechnologies Announces New Discoveries and Addition to its Board

Discovers three new CRISPR-Cas systems, findings published in the journal ScienceAppoints Paul Meister to ...

Shire plc : Statement re Possible Offer

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR ...